Sphenopalatine Ganglion Block Using the Tx360 Nasal Applicator for Trigeminal Neuralgia: A Prospective Observational Pilot Study.

Cureus · 2025 · PMC11891945 · PMID 40065877

Europe PMC DOI

hedged sentence

0.0975

closest p · 1.9× alpha

0.0975

boldest claim

The sentences

marginally significantp = 0.0975so close (0.05 < p ≤ 0.1)

The improvements in components that were not statistically significant were as follows: role limitations due to emotional problems improved by 20 units (64.3%, marginally significant, p = 0.0975), social functioning improved by 3.1 units (6%), and perceived health change improved by 3.3 units (10.4%).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.